Pegaptanib

Chemical formula: C₂₀H₄₀N₃NaO₁₀P  Molecular mass: 536.235 g/mol 

Therapeutic indications

Pegaptanib is indicated for:

Neovascular (wet) age-related macular degeneration (AMD)

Population group: only adults (18 years old or older)

Pegaptanib is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pegaptanib is contraindicated in the following cases:

Eye infection

Eye infection

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.